ACOT1-specific expression modulates metabolic reprogramming in diabetic cardiomyopathy: The role of SREBP1c lactylation in CD36-mediated lipotoxicity
Zeyu Liao, Yahui Fu, Ran Li · 2026
Read ACOT1-specific expression modulates metabolic reprogramming in diabetic cardiomyopathy: The role of SREBP1c lactylation in CD36-mediated lipotoxicity by Zeyu Liao, Yahui Fu, Ran Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13260214.txt.
Description
Zeyu Liao, Yahui Fu, and Ran Li trace a fat-handling enzyme that first protects, then abandons, the diabetic heart. Diabetic cardiomyopathy drowns heart cells in lipids, and the enzyme ACOT1 moves oddly across its stages. Their 2026 mouse study flips the enzyme up and down at each stage.
Early on, extra ACOT1 improved pumping and calmed oxidative stress, but its later disappearance worsened remodeling. The enzyme tags a fat-making switch, SREBP1c, with a lactylation mark under high lactate. That mark drives the switch into the nucleus and opens the fatty acid gate CD36. Fat floods in, poisoning the heart, a chain the authors propose blocking.
Catalog record
| CREATOR | Zeyu Liao, Yahui Fu, Ran Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |